Scientist for in vitro Drug-Drug interaction studies in the Department of Drug Metabolism

Requisition ID:  7461
Location: 

Copenhagen, Danish Capital Region, DK

Scientist for in vitro Drug-Drug interaction studies in the Department of Drug Metabolism

 

Do you enjoy assessing and predicting drug–drug interaction risk in humans? Are you motivated by scientific excellence and confident in leading complex scientific discussions across functions? Do you have a strong passion for understanding translational implications and like to grow on challenges?

 

If you are motivated by sound scientific curiosity, collaborative evaluation, and supportive teamwork within multidisciplinary projects, we look forward to hearing from you

 

 

Your new role

 

As DDI Scientist, you will play a key role in the evaluation and prediction of DDI risks for Lundbeck’s development compounds, ensuring safe and effective therapies reach patients. Moreover, you will represent the DDI group in project teams ensuring progress of our innovative and promising pipeline.

 

In order to support the projects, you will be designing, conducting, interpreting in vitro DDI studies, and develop PBPK models for DDI risk assessment. You will present the outcome to the project teams and guide decision-making in both preclinical and clinical development.

 

As an important part of your work, you will work in close collaboration with Contract Research Organisations (CRO’s), who are performing studies on behalf of Lundbeck. Furthermore, you will be responsible for studies performed in our laboratories and in that role be sparring and guiding our technicians. In addition, you will be driving the science within the DDI group together with your colleagues.

 

 

Your future team

 

The Department of Drug Metabolism is part of the Drug ADME Research Division within Non-Clinical Safety Research. Non-Clinical Safety Research is responsible for the safety evaluation of novel drug candidates for the treatment of diseases within the central nervous system. The Department of Drug Metabolism is responsible for providing non-clinical and human ADME data and data on drug-drug interaction potential for worldwide registration of new innovative medicines. We are a group of 13 scientists and technicians in total divided into to two teams (Drug-drug interaction and Metabolism). Our team, including this position, is based in Valby, Copenhagen, and we pride ourselves on fostering scientific excellence, a collaborative, supportive, and friendly work environment. We believe in open communication, continuous learning, and celebrating our successes together.

 

 

What you bring to the team

 

Our preferred candidate:

 

  • Holds a PhD in biochemistry, pharmacy, chemical engineering or equivalent.
  • Has experience within major drug metabolizing enzymes and transporters, including enzyme kinetics.
  • Has hands on experience with in vitro DDI assays, including LC-MS, would be an advantage.
  • Experience with PBPK modelling and simulations would be an advantage
  • Experience with DDI guidelines and preparation of regulatory summary documents (i.e. IB, IND, CTD) would be an advantage
  • Has experience from pharmaceutical industry.
  • Has clear focus on delivering high quality data in due time and is result oriented.
  • Is enthusiastic, ambitious, proactive and a true team player.
  • Has good communication skills and is fluent in English.

 

 

Our promise to you  

 

Lundbeck offers an inspiring workplace and innovative culture, where our curiosity, accountability and adaptability enable us to transform lives. We want to go faster and further on addressing the big unmet needs of people living with brain disorders. We offer rewarding careers with a mix of exciting tasks and development opportunities that are balanced with initiatives focused on your well-being.

 

We need every brain in the game, and at Lundbeck, we are committed to building a workforce that is as diverse as the people we serve. Read more about our commitment at www.lundbeck.com/global/about-us/our-commitment/diversity-and-inclusion.

 

 

Apply now

 

Can you see yourself in this role? We want to hear from you. Does this sound like your dream job, but you’re not sure if you meet all the requirements? We still want to hear from you!

 

Upload your CV and include a few lines about your motivation for applying. We ask you not to include a photo or personal information that does not relate to your professional experience.

 

If you have questions, please contact Mette G. Hvenegaard, Director, tlf. 30833174. Applications must be received by March 22nd, 2026.

Learn more about us at www.lundbeck.com, LinkedIn or Instagram (@h_lundbeck).

 

#EveryBrainInTheGame

 

This job ad is intended for individuals seeking a career opportunity with Lundbeck. We engage with recruitment and search firms where needed on the basis of a written agreement, and we do not accept unsolicited requests of any kind. If you work as a recruitment consultant, you are kindly instructed to refrain from contacting Lundbeck or the hiring manager directly with suggested candidates. If you violate this policy, you do so at your own risk and for your own account, and Lundbeck will not assume any liability nor pay any associated fees resulting from such violation. 

 

 

 

About Lundbeck

At Lundbeck, our most important contribution is easing the burden of the millions of people living with brain disorders. Whether it is migraine, depression, or other brain disorders, patients, their carers, and society as a whole depend on us.

Through cutting edge science and strong partnerships, we develop and market some of the world’s leading treatments, expanding into neuro-specialty and neuro-rare from our strong legacy within psychiatry and neurology.

The brain health challenge is real. Our commitment is real. Our impact is real.

About Lundbeck

 

At Lundbeck, our most important contribution is easing the burden of the millions of people living with brain disorders. Whether it is migraine, depression, or other brain disorders, patients, their carers, and society as a whole depend on us.

Through cutting edge science and strong partnerships, we develop and market some of the world’s leading treatments, expanding into neuro-specialty and neuro-rare from our strong legacy within psychiatry and neurology.

The brain health challenge is real. Our commitment is real. Our impact is real.